According to Daito Pharmaceutical latest financial reports the total debt is $24.15M, an increase of 53.32% to 2022. At the end of 2022 company had $15.75M total debt. This figure represents the debts and financial obligations that Daito Pharmaceutical combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $24.15M | 53.32% |
2022 | $15.75M | 11.35% |
2021 | $14.15M | 27.51% |
2020 | $11.09M | -48.91% |
2019 | $21.72M | - |